We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Clinical Management of Respiratory Adverse Events Associated With Amikacin Liposome Inhalation Suspension: Results From a Patient Survey.
- Authors
Swenson, Colin; Lapinel, Nicole C; Ali, Juzar
- Abstract
Patients with Mycobacterium avium complex lung disease treated with amikacin liposome inhalation suspension (ALIS) at 2 clinics in the United States were surveyed to assess the frequency and management of ALIS-associated respiratory adverse events. Most respondents experienced these events, but management through physician-guided measures (eg, bronchodilator use, oral rinses, and/or temporary dosing adjustments) resulted in symptomatic improvement.
- Subjects
UNITED States; AMIKACIN; PATIENT surveys; ADVERSE health care events; MYCOBACTERIUM avium; LUNG diseases; MYCOBACTERIUM avium paratuberculosis
- Publication
Open Forum Infectious Diseases, 2020, Vol 7, Issue 4, pN.PAG
- ISSN
2328-8957
- Publication type
Article
- DOI
10.1093/ofid/ofaa079